UCSD plans to expand the Metabolomics Workbench to include a wide range of clinical trials data including demographics and trial protocols.
The centers will generate genotype and whole-genome sequence data from the samples submitted by participants.
Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.
The six-year, $190 million Somatic Cell Genome Editing program aims to remove barriers that slow the adoption of genome editing for treating patients.
In a wide-ranging discussion, the two leaders touched upon vaccine development, infant mortality, US education, research funding, machine learning, and precision medicine.
Hospital will partner with several other institutions in this effort to support data-driven research into pediatric cancers and structural birth defects.
Biotech and academic leaders met with Trump administration officials to discuss NIH funding, ScienceInsider reports.
The funding will be used to develop new software and data structures to enable researchers to use the GO data for network-based analysis.
The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.
The company plans to develop a liquid biopsy assay that can identify patients most likely to benefit from treatment with checkpoint inhibitors.
The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.
The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.
Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.
In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.